Coenzyme-B12 therapy in acute viral hepatitis

Scand J Infect Dis. 1977;9(2):157-8. doi: 10.3109/inf.1977.9.issue-2.22.

Abstract

Extra vitamins are needed to repair tissue damage and compensate for diminished hepatic storage during viral hepatitis. Coenzyme-B12 has recently been synthesized and ought to have a favourable effect on the damaged liver cell as has previously been reported for cyanocobalamin, since it is better absorbed by oral administration and to a greater extent accumulated in the liver. Two groups of patients from the same hepatitis A epidemic were treated with either coenzyme-B12 or cyanocobalamin. A more rapid return of serum aminotransferase (S-ALAT) levels to normal was observed in the group treated with coenzyme-B12.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Acute Disease
  • Cobamides / therapeutic use*
  • Hepatitis, Viral, Human / drug therapy*
  • Humans
  • Vitamin B 12 / therapeutic use

Substances

  • Cobamides
  • Vitamin B 12